Edgerton Zachary J, Edgerton James R
Cardiopulmonary Research Science and Technology Institute, Dallas, Texas (Z. Edgerton) and Cardiac Surgery Specialists, The Heart Hospital, Baylor Regional Medical Center at Plano, Texas (J. Edgerton). Dr. Edgerton is a paid consultant for AtriCure, Inc. Zachary J. Edgerton has no financial interests to disclose.
Proc (Bayl Univ Med Cent). 2012 Jul;25(3):218-23. doi: 10.1080/08998280.2012.11928831.
Surgical therapy for patients with atrial fibrillation has undergone significant advances over the past 30 years. The Cox Maze III technique is currently the gold standard of care for these patients. However, Maze IV, a less complex procedure using alternative energy sources, is rapidly replacing the Cox Maze III in clinical practice. The use of alternative energy sources such as cryothermy and radiofrequency eliminates some of the "cut and sew" lesions of the Maze III, resulting in an easier and faster procedure with less morbidity. Video-assisted technology and hybrid procedures have further ushered in the future of surgical therapy. This article presents the latest surgical therapeutic options for patients with atrial fibrillation. The history of these procedures is presented, followed by a discussion of modern-era techniques, including concomitant ablation and standalone (also referred to as "lone") procedures. Finally, the article explores breaking developments and future directions for the surgical treatment of patients with atrial fibrillation.
在过去30年里，心房颤动患者的外科治疗取得了重大进展。Cox迷宫III技术目前是这些患者的护理金标准。然而，迷宫IV是一种使用替代能源的不太复杂的手术，在临床实践中正在迅速取代Cox迷宫III。使用冷冻疗法和射频等替代能源消除了迷宫III的一些“切割和缝合”损伤，从而使手术更简便、更快，发病率更低。视频辅助技术和杂交手术进一步开创了外科治疗的未来。本文介绍了心房颤动患者最新的外科治疗选择。介绍了这些手术的历史，随后讨论了现代技术，包括联合消融和独立（也称为“单独”）手术。最后，本文探讨了心房颤动患者外科治疗的突破性进展和未来方向。
